Malaria is an epidemic in India, occurring not only in rural areas, but also in large cities like New Delhi. The 2011 World Malaria Report estimates that about 70 percent of India’s population faces risk of malaria infection. About 95 percent of India’s population resides in malaria-endemic areas. With the monsoon season’s early arrival, India can expect malaria outbreaks to heighten earlier as well.
A persistent issue of which healthcare providers should be aware: patients may be buying anti-malarial drugs on the market that are counterfeit and therefore, not effective. Fake anti-malarial drugs are undermining efforts to reduce (and eradicate) malaria in India. Fake drugs mean patients are not cured, and are more likely to spread the disease to other individuals. Counterfeit drugs are becoming harder for even the trained eye to detect.
A new device is being launched by the Federal Drug Administration (FDA) in the United States that detects...
6 Comments